BR Biopharma, Inc. (NASDAQ:BRBI – Get Free Report) declared a quarterly dividend on Friday, May 8th. Shareholders of record on Tuesday, May 19th will be given a dividend of 0.147 per share on Friday, June 5th. This represents a c) annualized dividend and a yield of 4.1%. The ex-dividend date of this dividend is Tuesday, May 19th.
BR Biopharma Price Performance
NASDAQ BRBI opened at $14.41 on Friday. The company’s 50 day moving average price is $14.80. BR Biopharma has a 1-year low of $12.15 and a 1-year high of $67.01.
BR Biopharma (NASDAQ:BRBI – Get Free Report) last released its quarterly earnings results on Tuesday, March 31st. The company reported $0.09 earnings per share for the quarter. The firm had revenue of $25.95 million for the quarter.
About BR Biopharma
BRBI BR Partners SA, through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners SA is based in S?o Paulo, Brazil.
See Also
- Five stocks we like better than BR Biopharma
- Japan’s Stealth Bull Market: How U.S. Investors Can Get Exposure
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
Receive News & Ratings for BR Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BR Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
